From GDMT to TEER: management of secondary mitral regurgitation and the timing of transcatheter intervention

With the collaboration of the iHF initiative (improving Heart Function) and PCR Mitral Focus Group

Anchorperson: M. Adamo

Spokesperson: F. Verbrugge

Summary

Delve into the comprehensive management of secondary mitral regurgitation, from guideline-directed medical therapy (GDMT) to transcatheter edge-to-edge repair (TEER). This session elucidates the pathophysiology of atrial and ventricular secondary mitral regurgitation, explores optimized heart failure treatments, and reviews the latest evidence on TEER as a therapeutic option, enhancing clinical decision-making for optimal timing and intervention.

Learning Objectives

To understand the mechanisms of atrial and ventricular secondary mitral regurgitation and their implications for treatment
To understand the impact and optimal implementation of heart failure therapies in secondary mitral regurgitation
To hear the latest evidence concerning the use of TEER as a treatment option for patients with secondary mitral regurgitation

Presentations available when logged in:

Welcome and session objectives
Pathophysiological mechanisms of atrial and ventricular secondary mitral regurgitation
Heart failure treatments for secondary mitral regurgitation
TEER for secondary ventricular and atrial mitral regurgitation: current evidence and knowledge gaps
Session evaluation and key learnings

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

From GDMT to TEER: management of secondary mitral regurgitation and the timing of transcatheter intervention

With the collaboration of the iHF initiative (improving Heart Function) and PCR Mitral Focus Group

Learning Objectives

Log in or create account for free